| Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ... Nature medicine 23 (6), 703-713, 2017 | 2970 | 2017 |
| Intestinal Blautia is associated with reduced death from graft-versus-host disease RR Jenq, Y Taur, SM Devlin, DM Ponce, JD Goldberg, KF Ahr, ... Biology of Blood and Marrow Transplantation 21 (8), 1373-1383, 2015 | 743 | 2015 |
| Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes CC Coombs, A Zehir, SM Devlin, A Kishtagari, A Syed, P Jonsson, ... Cell stem cell 21 (3), 374-382. e4, 2017 | 687 | 2017 |
| Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation JU Peled, ALC Gomes, SM Devlin, ER Littmann, Y Taur, AD Sung, ... New England Journal of Medicine 382 (9), 822-834, 2020 | 522 | 2020 |
| Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice Y Shono, MD Docampo, JU Peled, SM Perobelli, E Velardi, JJ Tsai, ... Science translational medicine 8 (339), 339ra71-339ra71, 2016 | 510 | 2016 |
| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 476 | 2020 |
| Cancer therapy shapes the fitness landscape of clonal hematopoiesis KL Bolton, RN Ptashkin, T Gao, L Braunstein, SM Devlin, D Kelly, M Patel, ... Nature genetics 52 (11), 1219-1226, 2020 | 451 | 2020 |
| Molecular international prognostic scoring system for myelodysplastic syndromes E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ... NEJM evidence 1 (7), EVIDoa2200008, 2022 | 428 | 2022 |
| Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia E Tiacci, JH Park, L De Carolis, SS Chung, A Broccoli, S Scott, F Zaja, ... New England Journal of Medicine 373 (18), 1733-1747, 2015 | 352 | 2015 |
| Intestinal microbiota and relapse after hematopoietic-cell transplantation JU Peled, SM Devlin, A Staffas, M Lumish, R Khanin, ER Littmann, L Ling, ... Journal of Clinical Oncology 35 (15), 1650-1659, 2017 | 295 | 2017 |
| Lactose drives Enterococcus expansion to promote graft-versus-host disease CK Stein-Thoeringer, KB Nichols, A Lazrak, MD Docampo, ... Science 366 (6469), 1143-1149, 2019 | 263 | 2019 |
| Role of MRD status in relation to clinical outcomes in newly diagnosed multiple myeloma patients: a meta-analysis O Landgren, S Devlin, M Boulad, S Mailankody Bone marrow transplantation 51 (12), 1565-1568, 2016 | 204 | 2016 |
| Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies T Jain, A Knezevic, M Pennisi, Y Chen, JD Ruiz, TJ Purdon, SM Devlin, ... Blood advances 4 (15), 3776-3787, 2020 | 203 | 2020 |
| Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation MA Perales, JD Goldberg, J Yuan, G Koehne, L Lechner, ... Blood, The Journal of the American Society of Hematology 120 (24), 4882-4891, 2012 | 198 | 2012 |
| GPRC5D-targeted CAR T cells for myeloma S Mailankody, SM Devlin, J Landa, K Nath, C Diamonte, EJ Carstens, ... New England journal of medicine 387 (13), 1196-1206, 2022 | 195 | 2022 |
| Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma K Wudhikarn, ML Palomba, M Pennisi, M Garcia-Recio, JR Flynn, ... Blood cancer journal 10 (8), 79, 2020 | 172 | 2020 |
| T-cell exhaustion in multiple myeloma relapse after autotransplant: optimal timing of immunotherapy DJ Chung, KB Pronschinske, JA Shyer, S Sharma, S Leung, SA Curran, ... Cancer immunology research 4 (1), 61-71, 2016 | 171 | 2016 |
| Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy M Smith, A Dai, G Ghilardi, KV Amelsberg, SM Devlin, R Pajarillo, ... Nature medicine 28 (4), 713-723, 2022 | 156 | 2022 |
| Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma CS Sauter, MJ Matasar, J Meikle, H Schoder, GA Ulaner, JC Migliacci, ... Blood, The Journal of the American Society of Hematology 125 (16), 2579-2581, 2015 | 148 | 2015 |
| Multicolor flow cytometry and multigene next-generation sequencing are complementary and highly predictive for relapse in acute myeloid leukemia after allogeneic transplantation BM Getta, SM Devlin, RL Levine, ME Arcila, AS Mohanty, A Zehir, ... Biology of Blood and Marrow Transplantation 23 (7), 1064-1071, 2017 | 141 | 2017 |
